Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
08/2008
08/21/2008US20080200384 Quantify expression of gene encoding subtypes 1and 2 glutamate transporter, and epidermal growth factor; quantify protein level; compare to control; polymerase chain reaction using oligonucleotide primers specific to fragment of the EAAT1, EAAT2 or EGF genes; kit, antibody binds antigenic determinants
08/21/2008US20080200370 Method of treating drug addiction using dextro-morphine
08/21/2008US20080199865 Using allelic variation in interleukin-1RN variable number of tandem repeats as diagnostic/prognostic indicator of decrease cell division and aging characteristics
08/21/2008US20080199864 Methods for cell screening of compounds capable of modulating the activity of ubiquitin-ligase scf complexes and their uses
08/21/2008US20080199538 Using herbal supplements; mixture of plant extracts, phenylalanine, niacinamide , seeds and lavender
08/21/2008US20080199520 Cognition activators; antiaging agent;veterinary medicine
08/21/2008US20080199518 Using 5-fluoro-8-94-(6-methoxyquinolin-8-yl)piperazin-1-yl)piperidin-1-yl)quinoline; sustained release bead; core containing drug and multilayer overcoatings; cognition activators; anxiolytic agents; Parkinson's, Huntington's, Alzheimer's disease; psychological disorders
08/21/2008US20080199437 Lrp4/Corin Dopaminergic Neuron Progenitor Cell Markers
08/21/2008US20080199436 Binds to cerebrovascular endothelial cell; expression vectors; micelle, liposome or microcapsule used as carriers
08/21/2008US20080199435 IL-8 Like Protein
08/21/2008US20080199432 Role for sry in parkinson's disease
08/21/2008US20080199407 Drug Detoxification Protocol Using Microdosing
08/21/2008DE60037007T2 Angereicherte zentralnervensystem-zellpopulationen Enriched cns-cell populations
08/21/2008DE102007007318A1 Coating composition for bioactive textile materials, useful e.g. for producing wound dressings, comprises layer-forming inorganic nanoparticulate sol and active component, e.g. natural oil
08/21/2008CA2679849A1 Functionally selective alpha2c adrenoreceptor agonists
08/21/2008CA2678325A1 Use of ranolazine for the treatment of non-coronary microvascular diseases
08/21/2008CA2678069A1 Derivatives and analogs of chroman as functionally selective alpha2c adrenoreceptor agonists
08/21/2008CA2678036A1 Functionally selective alpha2c adrenoreceptor agonists
08/21/2008CA2677678A1 3,4-dihydro-1,4-benzoxazine, 3, 4-dihydro-1, 4-benzothiazine and 1,2,3,4-tetrahydro-quinoxaline derivatives as alpha2c adrenoreceptor agonists
08/21/2008CA2676944A1 2-aminooxazolines as taar1 ligands
08/21/2008CA2676715A1 Piperazine derivatives for treatment of ad and related conditions
08/21/2008CA2674773A1 Therapeutic effects of bryostatins, bryologs, and other related substances on head trauma-induced memory impairment and brain injury
08/21/2008CA2674752A1 3,4-dihydropyrrolo[1,2-a]pyrazin-1-yl amines useful as fast dissociating dopamine 2 receptor antagonists
08/21/2008CA2674100A1 Use of neuroprotective compounds for obtaining drugs for treating neurodegenerative diseases
08/21/2008CA2674097A1 New aminopyrrolo[1,2-.alpha.]indole et aminopyridazino[1,6-.alpha.]indole derivatives, method for preparing the same and pharmaceutical compositions containing the same
08/21/2008CA2674094A1 Process for preparing entacapone substantially free of z-isomer, synthesis intermediates thereof and a new crystalline form
08/21/2008CA2674087A1 6' substituted compounds having 5-ht6 receptor affinity
08/21/2008CA2674083A1 Novel triazabenzo[.alpha.]naphtho[2,l,8-cde]azulene derivatives, method for preparing the same and pharmaceutical compositions containing the same
08/21/2008CA2673573A1 Therapeutic effects of bryostatins, bryologs, and other related substances on ischemia/stroke-induced memory impairment and brain injury
08/21/2008CA2578493A1 A role for sry in parkinson's disease
08/20/2008EP1959013A1 Human circulating virus inhibitory peptide (VRIP) and its use
08/20/2008EP1958938A2 A process for the preparation of 10,11-dihydro-10-oxo-5H-dibenz[b,f]azepine-5-carboxamide
08/20/2008EP1958666A1 Heterocyclic-substituted alkanamides as therapeutic compounds
08/20/2008EP1958635A1 Treatment
08/20/2008EP1958634A2 Substituted piperidines as inhibitors of beta-secretase, cathepsin D, plasmepsin II and/or HIV protease
08/20/2008EP1957488A1 3-amino-2-arylpropyl azaindoles and uses thereof
08/20/2008EP1957486A1 Compositions and methods for modulating gated ion channels
08/20/2008EP1957480A1 Substituted oxindol-derivatives, medicaments containing said derivatives and use thereof
08/20/2008EP1957478A2 New compounds
08/20/2008EP1957475A1 Chromenones and their use as modulators of metabotropic glutamate receptors
08/20/2008EP1957467A2 Spirocyclic derivatives
08/20/2008EP1957462A2 Novel 2-amino-heterocycles udeful in the treatment of abeta-related pathologies
08/20/2008EP1957452A1 Novel forms of [r-(r*,r*)]-2-(4-fluorophenyl)-b,b-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-hept anoic acid magnesium
08/20/2008EP1957448A1 Substituted azacycloalkanes useful for treating cns conditions
08/20/2008EP1957121A2 Acute treatment of social phobia
08/20/2008EP1957106A2 Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
08/20/2008EP1957082A1 Use of high-dose oxazaphosphorine drugs for treating immune disorders
08/20/2008EP1957067A1 Indolone compounds useful to treat cognitive impairment
08/20/2008EP1956904A2 Use of low-dose ladostigil for neuroprotection
08/20/2008EP1756066B1 Tetrasubstituted imidazole derivatives as cannabinoid cb1 receptor modulators with a high cb1/cb2 receptor subtype selectivity
08/20/2008EP1737438B1 Alpha-aminoamide derivatives useful in the treatment of restless legs syndrome
08/20/2008EP1692129B1 Keto lactam compounds and use thereof
08/20/2008EP1670790B1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
08/20/2008EP1670770B1 Benzimidazole derivatives, compositions containing them, preparation therof and uses thereof
08/20/2008EP1587821B1 Compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding
08/20/2008EP1545537B9 Alpha-7 nicotinic receptor agonists and statins in combination
08/20/2008EP1523336B1 Targeted agents for nerve regeneration
08/20/2008EP1509618B1 Autoimmune conditions and nadph oxidase defects
08/20/2008EP1459765B1 6-fluorobicyclo 3.1.0 hexane derivatives
08/20/2008EP1456203B1 Ethylene diamine derivatives and their use as orexin-receptor antagonists
08/20/2008EP1451202B1 Aryl fused azapolycyclic compounds
08/20/2008EP1446500B1 A method for regulating immune function in primates using the foxp3 protein
08/20/2008EP1424071B1 Perfume compositions
08/20/2008EP1409654B1 Immunological control of beta-amyloid levels in vivo
08/20/2008EP1374887B1 Novel agents for ameliorating motor disorder
08/20/2008EP1363639B1 PYRROLO 2,3-d PYRIMIDINE AND THEIR USE AS PURINERGIC RECEPTOR ANTAGONISTS
08/20/2008EP1349552B1 PYRAZOLO[3,4-d]PYRIMIDINE DERIVATIVES AND THEIR USE AS PURINERGIC RECEPTOR ANTAGONISTS
08/20/2008EP1345955B1 Lactam dipeptide and its use in inhibiting beta-amyloid peptide release
08/20/2008EP1318993B1 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
08/20/2008EP1289993B9 Caspase inhibitors and uses thereof
08/20/2008EP1255547B1 Controlled-release compositions containing opioid agonist and antagonist
08/20/2008EP1240823B1 N-calcium channel knockout animal
08/20/2008EP1075493B1 Dna encoding snorf25 receptor
08/20/2008EP0826042B1 Genetic sequences and proteins related to alzheimer's disease, and uses therefor
08/20/2008CN101248105A Polymer conjugates of K-252a and derivatives thereof
08/20/2008CN101248088A Anti-il-23 antibodies
08/20/2008CN101248076A Acetylenic piperazines as metabotropic glutamate receptor antagonists
08/20/2008CN101248073A Heteroaryl-substituted diazatricycloalkanes and methods of use thereof
08/20/2008CN101248071A Bicyclic piperazines as metabotropic glutamate receptor antagonists
08/20/2008CN101248064A Nitrocatechol derivatives as COMT inhibitors
08/20/2008CN101248063A Prodrugs of pyrazoline compounds, their preparation and use as medicaments
08/20/2008CN101248053A N-oxides as prodrugs of piperazine and piperidine derivatives
08/20/2008CN101248046A Amide derivatives as kinase inhibitors
08/20/2008CN101248043A Novel 2-azetidinone derivatives as cholesterol absorption inhibitors useful for the treatment of hyperlipidaemic conditions
08/20/2008CN101247853A Substituted indole compounds having NOS inhibitory activity
08/20/2008CN101247837A Novel salts of conjugated psychotropic drugs and processes of preparing same
08/20/2008CN101247819A Methods for the treatment of anxiety and for identification of anxiolytic agents
08/20/2008CN101247810A Combination of a hypnotic agent and R(+)-alpha-(2,3-dimethoxy-phenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol and therapeutic application thereof
08/20/2008CN101247808A N-(arylalkyl)-1H-pyrrolopyridine-2-carboxamide derivatives, preparation and therapeutic use thereof
08/20/2008CN101247805A Tablet containing hardly soluble active ingredient
08/20/2008CN101247796A Composition for treatment of psychosis
08/20/2008CN101247794A Formulation for a viptadil
08/20/2008CN101247736A Compositions and methods for improving cellular survival after ischemic episode in the brain
08/20/2008CN101245107A Antihuman transferrin acceptor human source antibody and uses thereof
08/20/2008CN101245105A Anti-amyloid antibodies, compositions, methods and uses
08/20/2008CN101245062A Tetrahydroquinoline compound, preparation method and pharmaceutical composition
08/20/2008CN101244280A Interfere function of panaxoside Rg1 for self immunity myeloencephalitis mouse
08/20/2008CN101244264A New purpose of antialcoholic drug containing acetaldehyde dehydrogenase
08/20/2008CN101244250A Mind-pacifying body-building Chinese medicine for dropping drug
08/20/2008CN101244246A Chinese medicine composition for treating epilepsy and method of preparing the same
1 ... 664 665 666 667 668 669 670 671 672 673 674 675 676 677 678 679 680 681 682 683 684 ... 1833